Neutral endopeptidase inhibition: the potential of a new therapeutic approach in cardiovascular disease evolves.

Roland Veelken; Roland E Schmieder

doi:10.1097/00004872-200204000-00012

Neutral endopeptidase inhibition: the potential of a new therapeutic approach in cardiovascular disease evolves.

Roland Veelken (First author), Roland E Schmieder

Research output: Contribution to journal › Letter to the editor › peer-review

5 Citations (Web of Science)

Original language	English
Pages (from-to)	599-603
Journal	JOURNAL OF HYPERTENSION
Volume	20
Issue number	4
DOIs	https://doi.org/10.1097/00004872-200204000-00012
Publication status	Published - 2002

Keywords

ANGIOTENSIN-CONVERTING ENZYME
ATRIAL-NATRIURETIC-FACTOR
INDUCED DIABETIC RATS
ENDOTHELIN RECEPTOR
EXPRESSION
HYPERTENSION
CANDOXATRIL
RESPONSES
SEQUENCE
PEPTIDES

Access to Document

10.1097/00004872-200204000-00012

Cite this

Veelken, R., & Schmieder, R. E. (2002). Neutral endopeptidase inhibition: the potential of a new therapeutic approach in cardiovascular disease evolves. JOURNAL OF HYPERTENSION , 20(4), 599-603. https://doi.org/10.1097/00004872-200204000-00012

Veelken, Roland ; Schmieder, Roland E. / Neutral endopeptidase inhibition: the potential of a new therapeutic approach in cardiovascular disease evolves. In: JOURNAL OF HYPERTENSION 2002 ; Vol. 20, No. 4. pp. 599-603.

@article{d9b0ccea86334f6eb6f7d5f4f163f39b,

title = "Neutral endopeptidase inhibition: the potential of a new therapeutic approach in cardiovascular disease evolves.",

keywords = "ANGIOTENSIN-CONVERTING ENZYME, ATRIAL-NATRIURETIC-FACTOR, INDUCED DIABETIC RATS, ENDOTHELIN RECEPTOR, EXPRESSION, HYPERTENSION, CANDOXATRIL, RESPONSES, SEQUENCE, PEPTIDES",

author = "Roland Veelken and Schmieder, {Roland E}",

year = "2002",

doi = "10.1097/00004872-200204000-00012",

language = "English",

volume = "20",

pages = "599--603",

journal = "JOURNAL OF HYPERTENSION ",

issn = "0263-6352",

number = "4",

}

Veelken, R & Schmieder, RE 2002, 'Neutral endopeptidase inhibition: the potential of a new therapeutic approach in cardiovascular disease evolves.', JOURNAL OF HYPERTENSION , vol. 20, no. 4, pp. 599-603. https://doi.org/10.1097/00004872-200204000-00012

Neutral endopeptidase inhibition: the potential of a new therapeutic approach in cardiovascular disease evolves. / Veelken, Roland (First author); Schmieder, Roland E.
In: JOURNAL OF HYPERTENSION , Vol. 20, No. 4, 2002, p. 599-603.

Research output: Contribution to journal › Letter to the editor › peer-review

TY - JOUR

T1 - Neutral endopeptidase inhibition: the potential of a new therapeutic approach in cardiovascular disease evolves.

AU - Veelken, Roland

AU - Schmieder, Roland E

PY - 2002

Y1 - 2002

KW - ANGIOTENSIN-CONVERTING ENZYME

KW - ATRIAL-NATRIURETIC-FACTOR

KW - INDUCED DIABETIC RATS

KW - ENDOTHELIN RECEPTOR

KW - EXPRESSION

KW - HYPERTENSION

KW - CANDOXATRIL

KW - RESPONSES

KW - SEQUENCE

KW - PEPTIDES

U2 - 10.1097/00004872-200204000-00012

DO - 10.1097/00004872-200204000-00012

M3 - Letter to the editor

C2 - 11910290

SN - 0263-6352

VL - 20

SP - 599

EP - 603

JO - JOURNAL OF HYPERTENSION

JF - JOURNAL OF HYPERTENSION

IS - 4

ER -

Veelken R, Schmieder RE. Neutral endopeptidase inhibition: the potential of a new therapeutic approach in cardiovascular disease evolves. JOURNAL OF HYPERTENSION . 2002;20(4):599-603. doi: 10.1097/00004872-200204000-00012